Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA Total Current Liabilities
All obligations due within one year.
Biomea Fusion, Inc.NASDAQ: BMEA
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 53.1% from a year ago
Total current liabilities stood at $9.29M at the end of Q1 FY2026, down 53.1% from a year earlier and down 16.3% from the prior quarter. Over 3 fiscal years it compounded at -16.5% a year.
Context
- Total current liabilities amounted to 20.0% of total assets at the end of Q1 FY2026, down 16.0 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -53.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 11.1M USD
- Year-over-year change
- -48.8%
- 4-year CAGR
- +24.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.1M | -48.8% |
| FY2024 | 2024-12-31 | 21.67M | -5.2% |
| FY2023 | 2023-12-31 | 22.86M | +19.7% |
| FY2022 | 2022-12-31 | 19.1M | +311.9% |
| FY2021 | 2021-12-31 | 4.64M | — |
Total Current Liabilities vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's Mar 2026 total current liabilities of $9.29M is the 8th highest of the 9 companies compared; the peer median is $18.4M.
- Its year-over-year change of -53.1% is the lowest of 9, against a peer median of -2.1%.
- Total current liabilities amounts to 20.0% of total assets for BMEA, versus a peer median of 15.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $70.81M | -46.8% | +4.1% | 29.3% | |
| Mar 2026 | $38.36M | +49.9% | +32.8% | 20.2% | |
| Mar 2026 | $26.49M | +58.8% | +79.3% | 41.1% | |
| Mar 2026 | $20.18M | +7.7% | -4.7% | 11.3% | |
| Mar 2026 | $16.62M | +158.1% | — | 15.8% | |
| Mar 2026 | $15.41M | -18.0% | +35.8% | 15.5% | |
CBUSCibus, Inc. | Mar 2026 | $13.94M | -33.6% | +116.5% | 4.3% |
| Mar 2026 | $9.29M | -53.1% | -16.5% | 20.0% | |
| Mar 2026 | $8.6M | -11.9% | +1.8% | 8.9% | |
| Peer median (excluding BMEA) | $18.4M | -2.1% | +32.8% | 15.6% | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 145.74M | 111.9M | 176.87M | 58.28M | 55.81M |
| Short-term Investments | 27.78M | 1.15M | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 4.77M | 2.32M | 10.05M | 2.24M |
| Total Current Assets | 176.56M | 117.82M | 179.18M | 68.33M | 58.05M |
| Property, Plant & Equipment (Net) | 5.69M | 7.99M | 14.87M | 10.62M | 153K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 1.88M | 0 | 0 | 0 | 369K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.58M | 3.5M | 5.87M | 988K | 0 |
| Total Non-current Assets | 9.14M | 11.49M | 20.75M | 11.61M | 522K |
| Total Assets | 185.71M | 129.31M | 199.93M | 79.94M | 58.57M |
| Account Payables | 1.33M | 6.83M | 6.85M | 12.93M | 3.23M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 480K | 636K | 192K | 203K | 169K |
| Total Current Liabilities | 4.64M | 19.1M | 22.86M | 21.67M | 11.1M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 17.79M |
| Total Non-current Liabilities | 2.29M | 1.67M | 7.83M | 6.69M | 17.92M |
| Total Liabilities | 6.92M | 20.77M | 30.69M | 28.37M | 29.02M |
| Common Stock | 3K | 3K | 4K | 4K | 7K |
| Retained Earnings | (49.74M) | (131.57M) | (248.83M) | (387.25M) | (449.05M) |
| Accumulated OCI | (10K) | (1K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 178.78M | 108.54M | 169.24M | 51.57M | 29.55M |
| Total Debt | 2.85M | 2.29M | 10.3M | 8.77M | 1.59M |
| Net Debt | (142.89M) | (109.61M) | (166.57M) | (49.51M) | (54.22M) |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.